psyche
Restlessness / Jitteriness
Adverse effectRestlessness / Jitteriness is an adverse psyche effect involving a sense of unease, nervousness, excitability, or being unable to settle. It describes an uncomfortable state of heightened agitation, not improved focus or energy.
Restlessness / Jitteriness is categorized as a psyche effect, offering a focused starting point for understanding this term.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
Hatha YogapracticeUnclear
Based on one study. Strongest study: a randomized controlled trial.
One randomized trial found increased movement and movement intensity after exercise in the HC group. The finding measured movement, not necessarily a subjective feeling of restlessness or jitteriness.
Open the Hatha Yoga pageTranscendental MeditationpracticeUnclear
Based on one study. Strongest study: a randomized controlled trial.
A randomized trial in 2015 involving 17 people listed restless feet.
Open the Transcendental Meditation pageCoffee EnemapracticeUnclear
Based on one study.
Caffeine absorbed through the rectum may cause jitteriness or restlessness.
Open the Coffee Enema pageAcupuncturepracticesimple.meter.userReports
Based on one study.
Open the Acupuncture pageFocused Attention Meditationpracticesimple.meter.userReports
Based on one study.
Open the Focused Attention Meditation page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on5 listedHighest probability
- →PracticesHatha YogaCertaintyLowSourceClinical1 other source
One randomized trial found increased movement and movement intensity after exercise in the HC group. The finding measured movement, not necessarily a subjective feeling of restlessness or jitteriness.
Who was studied
- People with a condition
- ADHD
Open Hatha YogaStudy result
the HC showed a significant increase in movement after exercise (t(67) = 3.18, p = 0.002); ... movement intensity increased (t(67) = 5.24, p < .001)
- →PracticesTranscendental MeditationCertaintyLowSourceClinical1 other source
A randomized trial in 2015 involving 17 people listed restless feet.
- →PracticesCoffee EnemaCertaintyLowSourceReference knowledge1 other source
Caffeine absorbed through the rectum may cause jitteriness or restlessness.
Open Coffee EnemaStudy result
Rectal caffeine absorption may cause jitteriness or restlessness beyond the already listed anxiety increase.
- →PracticesAcupunctureCertaintyLowSourceAnecdotal1 other source
This effect was mentioned in 2 of 191 Reddit reports discussing it.
- →PracticesFocused Attention MeditationCertaintyLowSourceAnecdotal1 other source
This effect was mentioned in 2 of 237 Reddit reports discussing it.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Restlessness / Jitteriness is an adverse psyche effect involving a sense of unease, nervousness, excitability, or being unable to settle. It describes an uncomfortable state of heightened agitation, not improved focus or energy. It may occur with interventions such as Panax Ginseng, Green Tea Extract (EGCG), Caffeine, or Saffron Extract, particularly when stimulant sources are combined.
How interventions help
For restlessness or jitteriness, the relevant interventions are contributors rather than treatments. The clearest shared pattern is stimulation: caffeine-containing products and several interventions described as stimulating may produce nervousness, excitability, agitation, or a subjectively overstimulated feeling in some people. This includes Caffeine, Green Tea Extract (EGCG), Panax Ginseng, American Ginseng, Tyrosine, Tongkat Ali (Eurycoma), and Acetyl-L-Carnitine (ALCAR).
Risk may be more noticeable with higher doses, with additional caffeine or other stimulants, or in people who are more sensitive to stimulating effects. Combining products with similar effects can therefore make it harder to identify which intervention is contributing to the symptom. Restlessness has also been reported with interventions that do not fit a single stimulant pattern, including Saffron Extract, Bacopa Monnieri, SAM-e, Melatonin, CBD (Cannabidiol), Ashwagandha, 5-HTP, and Chlorella.
The available findings describe the experience rather than establishing a consistent onset, duration, or persistence after stopping. They also do not establish that every person using these interventions will experience restlessness. In practice, the most relevant distinctions are whether an intervention is caffeine-containing or stimulating, whether it is combined with other stimulants, and whether the individual appears sensitive to its effects.
Choosing guidance
When comparing options, pay attention to whether restlessness is linked to stimulation, amount, timing, or combinations. The clearest recurring pattern is greater concern with higher or excessive dosing, caffeine-containing products, added stimulants, and taking a stimulating option late in the day. This makes a single product easier to evaluate than several potentially stimulating products used together.
The speed and duration of this effect are not established consistently across the options. Some reports describe a short-lived experience, but that does not establish a predictable onset or duration for the group as a whole. Evidence also differs substantially: some entries have clinical support, including reviews and controlled studies, while others rely on pharmacology references or anecdotal reports. Clinical evidence is more directly informative for effects observed in people, but it still may not apply to every individual.
These options may be most relevant to different readers depending on their tolerance for stimulation and their preference for the type of evidence supporting a choice. People who are sensitive to caffeine or other stimulating effects may want to be especially cautious with products associated with higher-dose effects or stimulant combinations. Those seeking to minimize uncertainty may prefer options with clinical evidence rather than relying mainly on anecdotal reports, while recognizing that the available studies do not specify a single health status or establish how results transfer to every population.